Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gladstone DE"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 29
Tytuł:
Opinion Dynamics Systems via Biswas–Chatterjee–Sen Model on Solomon Networks.
Autorzy:
Filho, Edmundo Alves
Lima, Francisco Welington
Alves, Tayroni Francisco Alencar
Alves, Gladstone de Alencar
Plascak, Joao Antonio
Pokaż więcej
Temat:
SYSTEM dynamics
PHASE transitions
ISING model
CRITICAL exponents
COMPUTER simulation
Źródło:
Physics (2624-8174); Sep2023, Vol. 5 Issue 3, p873-882, 10p
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study.
Autorzy:
Hughes MS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sterling CH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Varadhan R; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ambinder RF; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jones RJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sweren RJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Rozati S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bolaños-Meade J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Luznik L; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Imus PH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ali SA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Borrello IM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Huff CA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jain T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ambinder A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gocke CB; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gladstone DE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Swinnen LJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Wagner-Johnston ND; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Fuchs EJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (12), pp. 2987-2991. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*
Lymphoma, T-Cell, Cutaneous*/drug therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Retrospective Studies ; Cyclophosphamide/adverse effects ; Transplantation Conditioning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
Autorzy:
Perkins B; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Showel M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Schoch L; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Imus PH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Karantanos T; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Yonescu R; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Morsberger L; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Ghiaur G; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Gladstone DE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Jones RJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, John Hopkins University, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jul; Vol. 63 (7), pp. 1617-1623. Date of Electronic Publication: 2022 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Immunoglobulin Heavy Chains*/genetics
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Mutation*
Precursor Cells, B-Lymphoid*/immunology
Animals ; Antigens, CD19 ; Antigens, CD34 ; Chromosome Aberrations ; Flow Cytometry ; Heterografts ; Humans ; Mice ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.
Autorzy:
Kreitman RJ; Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA. .
Dearden C; The Royal Marsden Hospital, Downs Road, Sutton, England, UK.
Zinzani PL; Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italia.; Istituto di Ematologia, 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università Degli Studi, Bologna, Italia.
Delgado J; Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain.
Robak T; Medical University of Łódź and Copernicus Memorial Hospital, Pabianicka 62, 90-001, Łódź, Poland.
le Coutre PD; Charité - Universitätsmedizin Berlin, Charitépl. 1, 10117, Berlin, Germany.
Gjertsen BT; Haukeland University Hospital and University of Bergen, Jonas Lies vei 65, 5021, Bergen, Norway.
Troussard X; Hospital Center University of Caen Normandie, Avenue de La Côte de Nacre, 14000, Caen, France.
Roboz GJ; Weill Cornell Medical College, The New York Presbyterian Hospital, 525 E 68th St, New York, NY, USA.
Karlin L; Hôpital Lyon Sud, Hospices Civils de Lyon, 165 Chemin du Grand Revoyet, 69310 Pierre-Bénite, Lyon, France.
Gladstone DE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 401 N Broadway, Baltimore, MD, USA.
Kuptsova-Clarkson N; AstraZeneca, One MedImmune Way, Gaithersburg, MD, USA.
Liu S; Acerta Pharma (AstraZeneca), 121 Oyster Point Blvd, South San Francisco, CA, USA.
Patel P; Acerta Pharma (AstraZeneca), 121 Oyster Point Blvd, South San Francisco, CA, USA.
Rotolo F; Innate Pharma, 117 Avenue de Luminy, BP 30191, 13276, Marseille, France.
Mitry E; Innate Pharma, 117 Avenue de Luminy, BP 30191, 13276, Marseille, France.
Pastan I; Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, 20892, USA.
Giles F; Developmental Therapeutics Consortium, 175 E Delaware Pl #7204, Chicago, IL, USA.
Pokaż więcej
Corporate Authors:
Study 1053 investigators
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 Feb 24; Vol. 14 (1), pp. 35. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Bacterial Toxins/*therapeutic use
Exotoxins/*therapeutic use
Leukemia, Hairy Cell/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Bacterial Toxins/adverse effects ; Exotoxins/adverse effects ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma.
Autorzy:
Thummalapalli R; Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.
Sena LA; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Probasco JC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gladstone DE; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Jan; Vol. 61 (1), pp. 228-230. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Bone Marrow Transplantation*
Hodgkin Disease*/complications
Hodgkin Disease*/therapy
Hashimoto Disease/*drug therapy
Immune Checkpoint Inhibitors/*adverse effects
Rituximab/*therapeutic use
Adolescent ; Encephalitis ; Hashimoto Disease/chemically induced ; Humans ; Male
SCR Disease Name:
Hashimoto's encephalitis
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.
Autorzy:
Gladstone DE; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Petri M; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Bolaños-Meade J; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Dezern AE; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Jones RJ; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Fine D; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Brodsky RA; Johns Hopkins Hospital and Health System, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2017 Jun; Vol. 26 (7), pp. 773-776. Date of Electronic Publication: 2016 Sep 30.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Marrow Transplantation/*methods
Cyclophosphamide/*administration & dosage
Lupus Erythematosus, Systemic/*therapy
Transplantation Conditioning/*methods
Adult ; Bone Marrow Transplantation/adverse effects ; Female ; Follow-Up Studies ; Humans ; Immunosuppressive Agents/administration & dosage ; Lupus Erythematosus, Systemic/physiopathology ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide.
Autorzy:
Lombardi LR; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Kanakry CG; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Zahurak M; b Biostatistics & Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA.
Durakovic N; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Bolaños-Meade J; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Kasamon YL; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Gladstone DE; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Matsui W; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Borrello I; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Huff CA; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Swinnen LJ; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Brodsky RA; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Ambinder RF; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Fuchs EJ; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Rosner GL; b Biostatistics & Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA.
Jones RJ; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Luznik L; a Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University , Baltimore , MD , USA and.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (3), pp. 666-75. Date of Electronic Publication: 2015 Oct 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Drug Monitoring*
Hematopoietic Stem Cell Transplantation*/adverse effects
Transplantation Conditioning*
Busulfan/*administration & dosage
Cyclophosphamide/*administration & dosage
Adult ; Aged ; Busulfan/adverse effects ; Busulfan/pharmacokinetics ; Cyclophosphamide/adverse effects ; Cyclophosphamide/pharmacokinetics ; Female ; Graft vs Host Disease/etiology ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Homologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Donor HLA-specific Abs: to BMT or not to BMT?
Autorzy:
Leffell MS; Immunogenetics Laboratory, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jones RJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Baltimore, MD, USA.
Gladstone DE; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Jun; Vol. 50 (6), pp. 751-8. Date of Electronic Publication: 2015 Feb 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Marrow Transplantation*
Tissue Donors*
Graft Survival/*immunology
HLA Antigens/*immunology
Isoantibodies/*immunology
Allografts ; Histocompatibility Testing ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor.
Autorzy:
Kern JB; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hii A; Clarient Inc, 31 Columbia, Aliso Viejo, CA, USA.
Kruse MJ; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Szabo Z; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Argani P; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hibbard MK; Clarient Inc, 31 Columbia, Aliso Viejo, CA, USA.
Gladstone DE; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Meyer C; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zheng R; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Borowitz MJ; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Duffield AS; The Johns Hopkins University School of Medicine, Baltimore, MD, USA .
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2015 Feb; Vol. 23 (1), pp. 75-7. Date of Electronic Publication: 2014 Oct 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Leukemia/*pathology
Neoplasms, Unknown Primary/*pathology
Rhabdomyosarcoma, Alveolar/*pathology
Female ; Humans ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Infusion of cryopreserved autologous lymphocytes using a standard peripheral i.v. catheter.
Autorzy:
Gladstone DE; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Davis-Sproul J; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Campian J; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Lemas MV; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Malatyali S; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Borrello I; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
King K; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Grossman SA; The Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2014 Aug; Vol. 49 (8), pp. 1119-20. Date of Electronic Publication: 2014 May 19.
Typ publikacji:
Clinical Trial; Comparative Study; Letter
MeSH Terms:
Central Venous Catheters*
Lymphocytes*
Glioma/*radiotherapy
Lymphocyte Transfusion/*methods
Adult ; Aged ; Autografts ; Cryopreservation ; Female ; Humans ; Lymphocyte Transfusion/instrumentation ; Male ; Middle Aged
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bortezomib salvage therapy in refractory acute adult T-cell leukemia/lymphoma.
Autorzy:
Hourigan CS; Myeloid Malignancies Section, National Heart, Lung and Blood Institute , Bethesda, MD , USA.
Forde PM
Ambinder RF
Gladstone DE
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2013 Nov; Vol. 54 (11), pp. 2563-4. Date of Electronic Publication: 2013 Apr 19.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Boronic Acids/*therapeutic use
Leukemia-Lymphoma, Adult T-Cell/*drug therapy
Pyrazines/*therapeutic use
Bortezomib ; Humans ; Leukemia-Lymphoma, Adult T-Cell/diagnosis ; Male ; Middle Aged ; Salvage Therapy ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 29

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies